PAVmed Inc (PAVMZ)
NASDAQ: PAVMZ
· Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Apr 30, 2025, 1:52 PM
PAVmed Inc Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 10K | 996K | 979K | 1.01M | 1.05M | 791K | 166K | 446K | 112K | 76K | n/a | 189K | 300K | 200K | n/a | n/a |
Cost of Revenue | 48K | 1.38M | 1.97M | 2.33M | 2.34M | 1.78M | 1.69M | 1.35M | 1.62M | 1.63M | 815K | 369K | 441K | 144K | 16K | 12K |
Gross Profit | -38K | -385K | -992K | -1.32M | -1.29M | -988K | -1.52M | -900K | -1.51M | -1.55M | -815K | -180K | -141K | 56K | -16K | -12K |
Operating Income | -5.19M | -11.58M | -13.68M | -14.04M | -16.38M | -15.53M | -16.48M | -20.4M | -24.5M | -23.31M | -23.48M | -19.46M | -19.68M | -13.67M | -12.97M | -8.08M |
Interest Income | 2K | 70K | 110K | 72K | 97K | 124K | 163K | 121K | 223K | 525K | 7K | 2K | n/a | n/a | n/a | n/a |
Pretax Income | 1.14M | 60.71M | -14.91M | -18.51M | -17.41M | -21.75M | -17.89M | -22.21M | -24.57M | -29.93M | -29.1M | -19.63M | -19.68M | -13.67M | -12.67M | -10.11M |
Net Income | 1.43M | 64.4M | -10.83M | -15.21M | -14.04M | -17.75M | -14.54M | 4.19B | -20.53M | -26.13M | -25.52M | -16.87M | -17.22M | -12.23M | -11.47M | -9.43M |
Selling & General & Admin | 4.34M | 9.57M | 11.25M | 10.78M | 11.5M | 10.87M | 10.99M | 14.56M | 15.82M | 15.06M | 16.74M | 13.35M | 18.36M | 5.99M | 6.74M | 4.76M |
Research & Development | 807K | 1.54M | 1.64M | 1.94M | 3.6M | 3.16M | 3.47M | 4.44M | 6.67M | 6.2M | 6.74M | 5.93M | 6.97M | 5.3M | 4.26M | 3.31M |
Other Expenses | n/a | 82K | -200K | 372M | 5.77M | 505K | -340K | 505K | 506K | 505K | -5.1M | -173K | -6.09M | 2.43M | 1.97M | 1.68M |
Operating Expenses | 5.15M | 11.19M | 12.69M | 12.72M | 15.1M | 14.54M | 14.96M | 19.5M | 23M | 21.76M | 23.48M | 19.28M | 19.54M | 13.72M | 12.97M | 8.08M |
Interest Expense | 7K | 12K | 11K | 16K | 19K | 159K | 228K | 183K | 223K | 525K | 523K | 2.76M | 2.46M | n/a | n/a | n/a |
Selling & Marketing Expenses | 155K | 2.92M | 4.24M | 4.31M | 4.69M | 4.02M | 3.88M | 4.54M | 5.76M | 4.74M | 4.9M | 3.92M | 8.89M | 2.29M | 1.88M | 1.39M |
Cost & Expenses | 5.2M | 12.57M | 14.66M | 15.05M | 17.43M | 16.32M | 16.65M | 20.85M | 24.62M | 23.39M | 23.48M | 19.65M | 19.98M | 13.87M | 12.97M | 8.08M |
Income Tax Expense | n/a | n/a | n/a | 4.28B | -3.37M | -4M | -3.28B | -4.21B | -4.04M | -3.81M | -3.58M | -2.76M | -2.46M | -1.44M | -1.2M | -679K |
Shares Outstanding (Basic) | 11.2M | 10.01M | 9.15M | 8.69M | 8.22M | 7.46M | 6.96M | 6.47M | 6.3M | 5.98M | 5.8M | 5.76M | 5.76M | 5.55M | 5.48M | 4.93M |
Shares Outstanding (Diluted) | 11.2M | 10.01M | 9.15M | 8.69M | 8.22M | 7.46M | 6.96M | 6.47M | 6.3M | 5.98M | 5.8M | 5.76M | 5.76M | 5.55M | 5.48M | 4.93M |
EPS (Basic) | 0.14 | 6.43 | -1.19 | -2.62 | -1.94 | -2.38 | -2.1 | -2.78 | -3.26 | -4.38 | -4.42 | -2.94 | -3 | -2.21 | -2.11 | -1.93 |
EPS (Diluted) | 0.14 | 6.43 | -1.19 | -2.62 | -1.94 | -2.38 | -2.1 | -2.78 | -3.26 | -4.38 | -4.42 | -2.94 | -3 | -2.21 | -2.11 | -1.93 |
EBITDA | 1.22M | 60.96M | -14.6M | -17.91M | -16.66M | -20.86M | -16.8M | -21.23M | -23.61M | -28.68M | -27.76M | -19.42M | -19.51M | -13.64M | -12.65M | -8.06M |
EBIT | 1.15M | 60.72M | -14.9M | -18.5M | -17.39M | -21.59M | -17.66M | -22.03M | -24.35M | -29.41M | -28.58M | -19.63M | -19.68M | -13.67M | -12.67M | -8.08M |
Depreciation & Amortization | 69K | 238K | 305K | 586K | 725K | 733K | 860K | 806K | 741K | 725K | 815K | 216K | 166K | 44K | 16K | 12K |